TGFβ2 stimulation reduces ERK1/2 and increases p38 activity, thereby suppressing metastasis in human head and neck squamous cell carcinoma (HNSCC) cells. This evidence concerns the gene MAPK14 and head and neck squamous cell carcinoma.